Velge Bertrand 4
4 · LifeMD, Inc. · Filed Aug 31, 2023
Insider Transaction Report
Form 4
LifeMD, Inc.LFMD
Velge Bertrand
Director
Transactions
- Award
Common Stock
2022-11-22+10,000→ 926,666 total(indirect: By Aliunde Ltd.) - Purchase
Common Stock
2023-08-29$3.58/sh+32,072$114,818→ 249,482 total(indirect: By LLC) - Purchase
Common Stock
2023-08-30$3.76/sh+40,000$150,400→ 289,482 total(indirect: By LLC) - Purchase
Common Stock
2023-08-31$3.93/sh+60,000$235,800→ 349,482 total(indirect: By LLC)
Footnotes (3)
- [F1]The grant of restricted shares vested incrementally on December 31, 2022 (50%), March 31, 2023 (25%), and June 16, 2023 (25%).
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.54 to $3.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the numbers of shares purchased at each separate price with the ranges set forth.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.86 to $3.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the numbers of shares purchased at each separate price with the ranges set forth.